Core Viewpoint - Spire Global, Inc. (SPIR) has seen a 7.2% increase in share price over the past four weeks, closing at $10.38, with analysts suggesting a potential upside of 59.9% based on a mean price target of $16.60 [1] Price Targets - The average price target consists of five estimates ranging from a low of $13 to a high of $20, with a standard deviation of $2.51, indicating variability among analysts [2] - The lowest estimate suggests a 25.2% increase from the current price, while the highest estimate indicates a potential upside of 92.7% [2] Analyst Sentiment - Analysts are optimistic about SPIR's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 8.2%, with one estimate moving higher and no negative revisions [12] Zacks Rank - SPIR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside [13]

Core Viewpoint - Kamada (KMDA) shows significant upside potential with a mean price target of $14.17, indicating a 106.9% increase from the current price of $6.85 [1] Price Targets and Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $3.13, suggesting variability among analysts [2] - The lowest estimate of $11 indicates a 60.6% increase, while the highest estimate suggests a 192% surge to $20 [2] - A low standard deviation indicates a high degree of agreement among analysts regarding price movement [9] Analyst Sentiment and Earnings Estimates - Analysts are increasingly optimistic about KMDA's earnings prospects, as reflected in higher EPS estimates [11] - The Zacks Consensus Estimate for the current year has risen by 11% over the past month, with two estimates increasing and no negative revisions [12] - KMDA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Price targets should not be the sole basis for investment decisions, as they can mislead investors [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Shares of Candel Therapeutics, Inc. (CADL) have gained 3.2% over the past four weeks to close the last trading session at $5.45, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $21 indicates a potential upside of 285.3%.The average comprises four short-term price targets ranging from a low of $15 to a high of $25, with a standard deviation of $4.90. While the lowest estimate ind ...

Group 1 - Pagaya Technologies Ltd. (PGY) closed at $17.13, with a 50.8% gain over the past four weeks, and a mean price target of $22.03 suggests a 28.6% upside potential [1] - The mean estimate consists of nine short-term price targets with a standard deviation of $6.97, indicating variability; the lowest estimate is $13.75 (19.7% decline), while the highest is $36 (110.2% increase) [2] - Analysts show strong agreement on PGY's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for PGY's current year earnings has increased by 84% over the last 30 days, with two estimates moving higher and no negative revisions [12] - PGY holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [13]

Group 1 - Janus International Group, Inc. (JBI) shares have increased by 18.5% over the past four weeks, closing at $8.25, with a mean price target of $10.90 indicating a potential upside of 32.1% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $2.97, where the lowest estimate is $7.50 (indicating a 9.1% decline) and the highest estimate is $14 (indicating a 69.7% increase) [2] - Analysts have shown strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 35.4% over the last 30 days [11][12] Group 2 - JBI currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - The consensus price target, while not entirely reliable, suggests a positive direction for JBI's stock price movement [13] - Analysts' price targets can often be overly optimistic due to business incentives, which may lead to inflated estimates [8]

Core Viewpoint - Evolv Technologies Holdings, Inc. (EVLV) has shown a significant price increase of 30% over the past four weeks, with a mean price target of $7.06 indicating a potential upside of 29.3% from the current price of $5.46 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $1.16, where the lowest estimate is $5.50 (0.7% increase) and the highest is $8.25 (51.1% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Agreement - There is a growing optimism among analysts about EVLV's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 23.3% over the past month, with no negative revisions reported [12] Zacks Rank and Investment Potential - EVLV holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13]

Core Viewpoint - Crexendo (CXDO) shows potential for significant upside, with a mean price target of $8.30 indicating a 55.1% increase from the current trading price of $5.35 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $0.97, suggesting variability in analyst predictions [2] - The lowest estimate of $7.50 indicates a 40.2% increase, while the highest estimate suggests an 86.9% surge to $10 [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price direction [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about CXDO's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 18.2% over the past month, with two estimates increasing and no negative revisions [12] - CXDO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Core Viewpoint - Arvinas, Inc. (ARVN) shows significant upside potential with a mean price target of $14.62, indicating a 94.9% increase from the current price of $7.50 [1] Price Targets and Estimates - The mean estimate consists of 17 short-term price targets with a standard deviation of $5.19, suggesting variability in analyst predictions [2] - The lowest estimate of $8 indicates a 6.7% increase, while the highest estimate suggests a 233.3% surge to $25 [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about ARVN's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 56.9% over the past month, with 11 estimates increasing and one decreasing [12] - ARVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Group 1 - AudioEye (AEYE) shares have increased by 15.7% over the past four weeks, closing at $12.55, with a mean price target of $22.40 indicating a potential upside of 78.5% [1] - The average price targets range from a low of $20 to a high of $25, with a standard deviation of $2.51, suggesting a potential increase of 59.4% to 99.2% from the current price level [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 10.4% [11][12] Group 2 - AEYE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While price targets are often viewed skeptically due to their tendency to mislead investors, a tight clustering of targets with low standard deviation suggests a high degree of agreement among analysts regarding price movement [9][10]

Core Viewpoint - Easterly Government Properties (DEA) has shown an 8.1% gain over the past four weeks, with a mean price target of $28.25 indicating a potential upside of 29.6% from the current price of $21.80 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $3.26, where the lowest estimate is $23.75 (8.9% increase) and the highest is $32.50 (49.1% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about DEA's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, one estimate has moved higher with no negative revisions, leading to a 0.8% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - DEA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13]